Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis

Rubella Virus, Cytomegalovirus (CMV), Herpes Simplex Virus-2 (HSV-2), Hepatitis B (HBV) and Hepatitis C virus (HCV) can cause serious fetal disease. The seropositivity rates of these agents vary among countries and geographic regions. This study aimed to analyze the prevalence rates and diagnostic m...

Full description

Saved in:
Bibliographic Details
Main Authors: Elmas Pinar Kahraman Kilbas, Ihsan Hakki Ciftci, Imdat Kilbas, Hande Toptan
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/14/1/37
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587776966524928
author Elmas Pinar Kahraman Kilbas
Ihsan Hakki Ciftci
Imdat Kilbas
Hande Toptan
author_facet Elmas Pinar Kahraman Kilbas
Ihsan Hakki Ciftci
Imdat Kilbas
Hande Toptan
author_sort Elmas Pinar Kahraman Kilbas
collection DOAJ
description Rubella Virus, Cytomegalovirus (CMV), Herpes Simplex Virus-2 (HSV-2), Hepatitis B (HBV) and Hepatitis C virus (HCV) can cause serious fetal disease. The seropositivity rates of these agents vary among countries and geographic regions. This study aimed to analyze the prevalence rates and diagnostic methods used in studies investigating the seroprevalence of viral pathogens in the TORCH group among pregnant women in Turkey between 2005 and 2024. A systematic search was conducted using electronic databases between January 2005 and January 2024. A total of 60 studies meeting the inclusion criteria were included. Data quality control was assessed using the Joanna Briggs Institute guideline prevalence studies checklist. Heterogeneity was measured using the I-squared (I<sup>2</sup>) statistic in the Comprehensive Meta Analysis (CMA) program. The average seropositivity rates for Rubella, CMV, HSV-2, HBV and HCV in Turkey were determined as 91.18%, 94.81%, 35.52%, 1.66% and 0.25%, respectively. When the diagnostic methods were examined, it was determined that ELISA and ECLIA methods were used most frequently. The seropositivity of the agents did not show statistically significant differences according to the year periods, geographical regions and age of the patients (<i>p</i> > 0.05). The highest prevalence rates of Rubella and HSV-2 in pregnant women were reported in the Mediterranean region, the highest prevalence rates of CMV and HCV in the Southeastern Anatolia region and the highest seroprevalence of Anti HBs in the Marmara region. The results of this study support the necessity of increasing public awareness in the control of fetal infection caused by TORCH viral agents, prenatal screening, vaccination for Rubella and HBV and compliance with hygiene conditions for agents such as CMV, HSV-2 and HCV. The results of this study highlight the need to increase public awareness on prenatal screening for the control of fetal infection caused by all TORCH viral agents, vaccination for Rubella and HBV and compliance with hygiene conditions for agents such as CMV, HSV-2 and HCV.
format Article
id doaj-art-ce9adacf0d6c40d0adbfb2b2eef55c6d
institution Kabale University
issn 2076-0817
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj-art-ce9adacf0d6c40d0adbfb2b2eef55c6d2025-01-24T13:44:41ZengMDPI AGPathogens2076-08172025-01-011413710.3390/pathogens14010037Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-AnalysisElmas Pinar Kahraman Kilbas0Ihsan Hakki Ciftci1Imdat Kilbas2Hande Toptan3Department of Medical Laboratory Techniques, Health Services Vocational School, Fenerbahce University, 34758 Istanbul, TurkeyDepartment of Medical Microbiology, Faculty of Medicine, Sakarya University, 54100 Sakarya, TurkeyMedical Microbiology Doctorate Program, Institute of Health Sciences, Istanbul University, 34093 Istanbul, TurkeyDepartment of Medical Microbiology, Faculty of Medicine, Sakarya University, 54100 Sakarya, TurkeyRubella Virus, Cytomegalovirus (CMV), Herpes Simplex Virus-2 (HSV-2), Hepatitis B (HBV) and Hepatitis C virus (HCV) can cause serious fetal disease. The seropositivity rates of these agents vary among countries and geographic regions. This study aimed to analyze the prevalence rates and diagnostic methods used in studies investigating the seroprevalence of viral pathogens in the TORCH group among pregnant women in Turkey between 2005 and 2024. A systematic search was conducted using electronic databases between January 2005 and January 2024. A total of 60 studies meeting the inclusion criteria were included. Data quality control was assessed using the Joanna Briggs Institute guideline prevalence studies checklist. Heterogeneity was measured using the I-squared (I<sup>2</sup>) statistic in the Comprehensive Meta Analysis (CMA) program. The average seropositivity rates for Rubella, CMV, HSV-2, HBV and HCV in Turkey were determined as 91.18%, 94.81%, 35.52%, 1.66% and 0.25%, respectively. When the diagnostic methods were examined, it was determined that ELISA and ECLIA methods were used most frequently. The seropositivity of the agents did not show statistically significant differences according to the year periods, geographical regions and age of the patients (<i>p</i> > 0.05). The highest prevalence rates of Rubella and HSV-2 in pregnant women were reported in the Mediterranean region, the highest prevalence rates of CMV and HCV in the Southeastern Anatolia region and the highest seroprevalence of Anti HBs in the Marmara region. The results of this study support the necessity of increasing public awareness in the control of fetal infection caused by TORCH viral agents, prenatal screening, vaccination for Rubella and HBV and compliance with hygiene conditions for agents such as CMV, HSV-2 and HCV. The results of this study highlight the need to increase public awareness on prenatal screening for the control of fetal infection caused by all TORCH viral agents, vaccination for Rubella and HBV and compliance with hygiene conditions for agents such as CMV, HSV-2 and HCV.https://www.mdpi.com/2076-0817/14/1/37RubellaCytomegalovirusHepatitis BHepatitis CHerpes Simplex Virus
spellingShingle Elmas Pinar Kahraman Kilbas
Ihsan Hakki Ciftci
Imdat Kilbas
Hande Toptan
Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis
Pathogens
Rubella
Cytomegalovirus
Hepatitis B
Hepatitis C
Herpes Simplex Virus
title Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis
title_full Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis
title_fullStr Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis
title_full_unstemmed Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis
title_short Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis
title_sort seroprevalence of torch viral agents in pregnant women in turkey systematic review and meta analysis
topic Rubella
Cytomegalovirus
Hepatitis B
Hepatitis C
Herpes Simplex Virus
url https://www.mdpi.com/2076-0817/14/1/37
work_keys_str_mv AT elmaspinarkahramankilbas seroprevalenceoftorchviralagentsinpregnantwomeninturkeysystematicreviewandmetaanalysis
AT ihsanhakkiciftci seroprevalenceoftorchviralagentsinpregnantwomeninturkeysystematicreviewandmetaanalysis
AT imdatkilbas seroprevalenceoftorchviralagentsinpregnantwomeninturkeysystematicreviewandmetaanalysis
AT handetoptan seroprevalenceoftorchviralagentsinpregnantwomeninturkeysystematicreviewandmetaanalysis